Earnings ·
Prenetics Global Limited reported Q2 2026 total revenue of $46.5 million, up approximately 3.9x year-over-year, with…
PREPrenetics Global Ltd
Prenetics Global Limited reported Q2 2026 total revenue of $46.5 million, up approximately 3.9x year-over-year, with its flagship brand IM8 contributing $45.0 million. The company raised full-year FY2026 total revenue guidance to $220–230 million and initiated FY2027 IM8 revenue guidance of over $400 million. Management announced that consolidated Adjusted Free Cash Flow turned positive in July 2026, with expectations for continued positivity through Q3 and beyond. Additionally, Prenetics completed a $40 million share repurchase program during the quarter. Prenetics Global Limited operates in the consumer health industry, focusing on premium daily nutrition supplements under its IM8 brand.